Edition:
India

Sun Pharma Advanced Research Company Ltd (SPRC.NS)

SPRC.NS on National Stock Exchange of India

498.05INR
2:52pm IST
Change (% chg)

Rs1.20 (+0.24%)
Prev Close
Rs496.85
Open
Rs501.00
Day's High
Rs507.20
Day's Low
Rs494.50
Volume
110,558
Avg. Vol
595,139
52-wk High
Rs532.00
52-wk Low
Rs272.00

Chart for

About

Sun Pharma Advanced Research Company Limited is engaged in the research and experimental development on natural sciences and engineering (Pharmacy). The Company operates through Pharmaceuticals Research & Development segment. Its programs include Xelpros, Elepsia XR, Baclofen GRS, Paclitaxel Injection Concentrate for Nanodispers... (more)
No analyst recommendations are available for .

Overall

Beta: 1.30
Market Cap(Mil.): Rs96,005.50
Shares Outstanding(Mil.): 246.90
Dividend: --
Yield (%): --

Financials

BRIEF-Sun Pharma Advanced Research Co announces top-line results of action study for Baclofen GRS

* Announces top-line results of phase III efficacy study & duration of action study for Baclofen GRS

06 Oct 2017

TABLE-India's Sun Pharma Advanced Research June qtr loss widens

Aug 5 Three months ended June 30 versus the same period a year earlier (in million rupees) June 2017 June 2016 Net loss 788.4 361.4 Total Income 246.2 245.0 Note: Sun Pharma Advanced Research Company Ltd is a pharmaceuticals research and development company. (Reporting by Malini Menon in NEW DELHI; Editing by Paul Tait)

05 Aug 2017

Earnings vs. Estimates